Ocean Biomedical, Inc. (OCEA) stock
Close on Oct 19, 2026Market cap $45.51KP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Mar 31, 2025
Valuation
- Market cap
- $45.51K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$30.72M
- EPS, diluted
- -$0.91
- Book value per share
- -$1.02
- Diluted shares
- 91M
Trading
- Previous close
- $0.00
- Open
- $0.00
- Day's range
- $0.00 – $0.00
- Volume
- 3,143
- Average volume (20 days)
- 48,824
Market cap history
Month-end market cap since 2023, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | OCEA | S&P 500 | Difference | OCEA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -44.4% | +0.6% | −45.1 pts | ||
| 3 months | +25.0% | +3.4% | +21.6 pts | ||
| Year to date | 0.0% | +13.3% | −13.3 pts | ||
| 1 year | -50.0% | +16.6% | −66.6 pts | ||
| 3 years | -100.0% | +86.4% | −186.4 pts | -93.7% | +23.1% |
Four years at a glance
Fiscal years 2021 to 2024 and trailing twelve months, USD
Operating income
Net income
EPS, diluted
Press releases
Releases Ocean Biomedical filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- Update
- Update
- Update
- Update
About Ocean Biomedical
Pharmaceutical Preparations
Ocean Biomedical, Inc. is a biopharmaceutical enterprise engaged in licensing, discovering, and conducting clinical development of therapeutic product candidates. The company focuses on progressing preclinical assets through Investigational New Drug-enabling studies and prospective clinical trials, targeting indications such as fibrosis. Ocean Biomedical relies on acquiring licenses from academic institutions and partnering with research organizations, manufacturing suppliers, and healthcare distribution partners to advance and prepare its therapeutic programs for commercialization rather than selling finished products to consumer retail markets.
Company profile, executives and historyOcean Biomedical stock: common questions
What is Ocean Biomedical's stock price?
OCEA closed at $0.00 on Oct 19, 2026, down 16.67% on the day.
What is Ocean Biomedical's market cap?
Ocean Biomedical was worth $45.51K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is OCEA's P/E ratio?
Ocean Biomedical lost money over the twelve months to Mar 31, 2025 (diluted EPS -$0.91), so it has no meaningful P/E ratio.
Does Ocean Biomedical pay a dividend?
No. Ocean Biomedical has not paid a cash dividend over the last twelve months.
How has OCEA stock performed over the past year?
Including dividends, OCEA returned -50.0% over the past year, against +16.6% for the S&P 500.
Who are Ocean Biomedical's competitors?
Companies most similar to Ocean Biomedical by business, industry and size include OCS, EOCN, NBP, CDT, PRQR.
See a number that looks wrong?